An open-source genetic algorithm for determining optimal seed distributions for low-dose-rate prostate brachytherapy

Brachytherapy

Volumn 14, Issue 5, 2015, Pages 692-702

  McGeachy, P ^a,b   Madamesila, J ^a,b   Beauchamp, A ^b   Khan, R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Genetic algorithm; Low dose rate; Open source; Optimization; Prostate brachytherapy; Seed distribution

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; BRACHYTHERAPY IMPLANT; CLINICAL ARTICLE; DOSIMETRY; EDEMA; GENETIC ALGORITHM; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SIZE; RADIATION DOSE REDUCTION; RECTUM; URETHRA; UROGENITAL TRACT DISEASE; ADVERSE EFFECTS; ALGORITHM; ORGAN SIZE; ORGANS AT RISK; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; PROSTHESIS IMPLANTATION; RADIATION DOSE; RADIATION RESPONSE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING SYSTEM; RETROSPECTIVE STUDY; VALIDATION STUDY;

ALGORITHMS; BRACHYTHERAPY; HUMANS; MALE; ORGAN SIZE; ORGANS AT RISK; PROSTATE; PROSTATIC NEOPLASMS; PROSTHESIS IMPLANTATION; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTUM; RETROSPECTIVE STUDIES; URETHRA;

EID: 84940450965     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2015.04.007     Document Type: Article

References (39)

1. Grimm P.D., Blasko J.C., Sylvester J.E., et al. 10-Year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy. Int J Radiat Oncol Biol Phys 2001, 51:31-40.
2. Uesugi T., Saika T., Edamura K., et al. Primary Gleason grade 4 impact on biochemical recurrence after permanent interstitial brachytherapy in Japanese patients with low- or intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 2012, 82:219-223.
3. Zelefsky M.J., Hollister T., Raben A., et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2000, 47:1261-1266.
4. Yue N., Mori J., Nath R., et al. External beam radiotherapy boosts to reduce the impact caused by edema in prostate permanent seed implants. Phys Med Biol 2006, 51:2267-2277.
5. Cheung A.K., Chen M.H., Moran B.J., et al. The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement. Brachytherapy 2010, 9:145-150.
6. Merrick G.S., Butler W.M., Wallner K.E., et al. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005, 61:32-43.
7. Merrick G.S., Wallner K.E., Butler W.M., Blasko J.C. Permanent prostate brachytherapy: Is supplemental external-beam radiation therapy necessary?. Oncology (Williston Park) 2006, 20:514-525.
8. Khaksar S.J., Langley S.E.M., Lovell D., Laing R.W. Interstitial low dose rate brachytherapy for prostate Cancer-a focus on intermediate- and high-risk disease. Clin Oncol 2006, 18:513-518.
9. Ho A.Y., Burri R.J., Cesaretti J.A., et al. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 2009, 75:16-22.
10. Rivard M.J., Butler W.M., Devlin P.M., et al. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103. Brachytherapy 2007, 6:34-37.
11. Davis B.J., Horwitz E.M., Lee W.R., et al. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy 2012, 11:6-19.
12. Pouliot J., Tremblay D., Roy J., Filice S. Optimization of permanent 125I prostate implants using fast simulated annealing. Int J Radiat Oncol Biol Phys 1996, 36:711-720.
13. Yang G., Reinstein L.E., Pai S., et al. A new genetic algorithm technique in optimization of permanent 125I prostate implants. Med Phys 1998, 25:2308-2315.
14. Lessard E., Kwa S.L.S., Pickett B., et al. Class solution for inversely planned permanent prostate implants to mimic an experienced dosimetrist. Med Phys 2006, 33:2773-2782.
15. Yu Y., Schell M.C. A genetic algorithm for the optimization of prostate implants. Med Phys 1996, 23:2085-2091.
16. D'Souza W.D., Meyer R.R., Thomadsen B.R., Ferris M.C. An iterative sequential mixed-integer approach to automated prostate brachytherapy treatment plan optimization. Phys Med Biol 2001, 46:297-322.
17. Lee E.K., Gallagher R.J., Silvern D., et al. Treatment planning for brachytherapy: An integer programming model, two computational approaches and experiments with permanent prostate implant planning. Phys Med Biol 1999, 44:145-165.
18. Lee E.K., Zaider M. Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys 2003, 56:854-861.
19. Chen Y., Boyer A.L., Xing L. A dose-volume histogram based optimization algorithm for ultrasound guided prostate implants. Med Phys 2000, 27:2286-2292.
20. Yoo S., Kowalok M.E., Thomadsen B.R., Henderson D.L. Treatment planning for prostate brachytherapy using region of interest adjoint functions and a greedy heuristic. Phys Med Biol 2003, 48:4077-4090.
21. Yoo S., Kowalok M.E., Thomadsen B.R., Henderson D.L. A greedy heuristic using adjoint functions for the optimization of seed and needle configurations in prostate seed implant. Phys Med Biol 2007, 52:815-828.
22. Cunha J.A.M., Pickett B., Pouliot J. Inverse planning optimization for hybrid prostate permanent-seed implant brachytherapy plans using two source strengths. J Appl Clin Med Phys 2010, 11:3096.
23. Sumida I., Shiomi H., Oh R.J., et al. An optimization algorithm of dose distribution using attraction-repulsion model (application to low-dose-rate interstitial brachytherapy). Int J Radiat Oncol Biol Phys 2004, 59:1217-1223.
24. Deasy J.O., Blanco A.I., Clark V.H. CERR: A computational environment for radiotherapy research. Med Phys 2003, 30:979-985.
25. Fedorov A., Beichel R., Kalpathy-Cramer J., et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging 2012, 30:1323-1341.
26. Printer C., Lasso A., Wang A., et al. SlicerRT: Radiation therapy research toolkit for 3D slicer. Med Phys 2012, 39:6332-6337.
27. Goldberg D.E. Genetic Algorithms in Search, Optimization, and Machine Learning 1989, Addison-Wesley, New York, USA. 1st ed.
28. Lessard E. Development and clinical introduction of an inverse planning dose optimization by simulated annealing (IPSA) for high dose rate brachytherapy. Med Phys 2004, 31:2935.
29. Rivard M.J., Coursey B.M., DeWerd L.A., et al. Update of AAPM Task Group No. 43 report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004, 31:633-674.
30. Collins-Fekete C.A., Plamondon M., Martin A.G., et al. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy. Med Phys 2014, 41:101704.
31. Saw C.B., Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys 1991, 20:135-139.
32. Dose and Volume Specifications for Reporting Interstitial Therapy, ICRU Report 58 1997, ICRU, ICRU, Bethesda, USA.
33. Merrick G.S., Zelefsky M.J., Sylvester J., et al. American Brachytherapy Society Prostate Low-Dose Rate Task Group 2015, Available at:, Accessed March 25, 2015. https://www.americanbrachytherapy.org/guidelines/prostate_low-doseratetaskgroup.pdf.
34. Crook J. The role of brachytherapy in the definitive management of prostate cancer. Cancer Radiother 2011, 15:230-237.
35. Merrick G.S., Butler W.M., Wallner K.E., et al. Variability of prostate brachytherapy pre-implant dosimetry: A multi-institutional analysis. Brachytherapy 2005, 4:241-251.
36. Chira C., Delouya G., Larrivée S., et al. Prostate volume changes during permanent seed brachytherapy: An analysis of intra-operative variations, predictive factors and clinical implication. Radiat Oncol 2013, 8:177.
37. Yue N., Dicker A.P., Nath R., Waterman F.M. The impact of edema on planning 125I and 103Pd prostate implants. Med Phys 1999, 26:763-767.
38. Keyes M., Miller S., Moravan V., et al. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: Long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys 2009, 73:1023-1032.
39. Ohashi T., Yorozu A., Toya K., et al. Predictive factors of acute urinary retention requiring catheterization following 125I prostate brachytherapy. Jpn J Clin Oncol 2006, 36:285-289.